These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
348 related items for PubMed ID: 15658869
21. Synthesis and biological activity of fluorinated combretastatin analogues. Alloatti D, Giannini G, Cabri W, Lustrati I, Marzi M, Ciacci A, Gallo G, Tinti MO, Marcellini M, Riccioni T, Guglielmi MB, Carminati P, Pisano C. J Med Chem; 2008 May 08; 51(9):2708-21. PubMed ID: 18396857 [Abstract] [Full Text] [Related]
22. Novel benzylidene-9(10H)-anthracenones as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization. Prinz H, Ishii Y, Hirano T, Stoiber T, Camacho Gomez JA, Schmidt P, Düssmann H, Burger AM, Prehn JH, Günther EG, Unger E, Umezawa K. J Med Chem; 2003 Jul 17; 46(15):3382-94. PubMed ID: 12852768 [Abstract] [Full Text] [Related]
23. Identification of novel and improved antimitotic agents derived from noscapine. Anderson JT, Ting AE, Boozer S, Brunden KR, Crumrine C, Danzig J, Dent T, Faga L, Harrington JJ, Hodnick WF, Murphy SM, Pawlowski G, Perry R, Raber A, Rundlett SE, Stricker-Krongrad A, Wang J, Bennani YL. J Med Chem; 2005 Nov 17; 48(23):7096-8. PubMed ID: 16279766 [Abstract] [Full Text] [Related]
24. Effects of altering the electronics of 2-methoxyestradiol on cell proliferation, on cytotoxicity in human cancer cell cultures, and on tubulin polymerization. Edsall AB, Mohanakrishnan AK, Yang D, Fanwick PE, Hamel E, Hanson AD, Agoston GE, Cushman M. J Med Chem; 2004 Oct 07; 47(21):5126-39. PubMed ID: 15456256 [Abstract] [Full Text] [Related]
25. New naphthylcombretastatins. Modifications on the ethylene bridge. Sánchez Maya AB, Pérez-Melero C, Salvador N, Peláez R, Caballero E, Medarde M. Bioorg Med Chem; 2005 Mar 15; 13(6):2097-107. PubMed ID: 15727863 [Abstract] [Full Text] [Related]
26. Interaction of 4-arylcoumarin analogues of combretastatins with microtubule network of HBL100 cells and binding to tubulin. Rappl C, Barbier P, Bourgarel-Rey V, Grégoire C, Gilli R, Carre M, Combes S, Finet JP, Peyrot V. Biochemistry; 2006 Aug 01; 45(30):9210-8. PubMed ID: 16866367 [Abstract] [Full Text] [Related]
27. New antitubulin derivatives in the combretastatin A4 series: synthesis and biological evaluation. Borrel C, Thoret S, Cachet X, Guénard D, Tillequin F, Koch M, Michel S. Bioorg Med Chem; 2005 Jun 01; 13(11):3853-64. PubMed ID: 15863010 [Abstract] [Full Text] [Related]
28. Synthesis, biological activity, and quantitative structure-activity relationship study of azanaphthalimide and arylnaphthalimide derivatives. Braña MF, Gradillas A, Gómez A, Acero N, Llinares F, Muñoz-Mingarro D, Abradelo C, Rey-Stolle F, Yuste M, Campos J, Gallo MA, Espinosa A. J Med Chem; 2004 Apr 22; 47(9):2236-42. PubMed ID: 15084122 [Abstract] [Full Text] [Related]
29. Synthesis and activity of Combretastatin A-4 analogues: 1,2,3-thiadiazoles as potent antitumor agents. Wu M, Sun Q, Yang C, Chen D, Ding J, Chen Y, Lin L, Xie Y. Bioorg Med Chem Lett; 2007 Feb 15; 17(4):869-73. PubMed ID: 17174089 [Abstract] [Full Text] [Related]
30. Sulfonate derivatives of naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-anthracenone as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization. Zuse A, Schmidt P, Baasner S, Böhm KJ, Müller K, Gerlach M, Günther EG, Unger E, Prinz H. J Med Chem; 2007 Nov 29; 50(24):6059-66. PubMed ID: 17973361 [Abstract] [Full Text] [Related]
31. Synthesis and cytotoxic evaluation of combretafurazans. Tron GC, Pagliai F, Del Grosso E, Genazzani AA, Sorba G. J Med Chem; 2005 May 05; 48(9):3260-8. PubMed ID: 15857132 [Abstract] [Full Text] [Related]
32. N-Phenyl-N'-(2-chloroethyl)urea analogues of combretastatin A-4: Is the N-phenyl-N'-(2-chloroethyl)urea pharmacophore mimicking the trimethoxy phenyl moiety? Fortin S, Moreau E, Lacroix J, Teulade JC, Patenaude A, C-Gaudreault R. Bioorg Med Chem Lett; 2007 Apr 01; 17(7):2000-4. PubMed ID: 17291753 [Abstract] [Full Text] [Related]
33. Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents. Gurjar MK, Wakharkar RD, Singh AT, Jaggi M, Borate HB, Shinde PD, Verma R, Rajendran P, Dutt S, Singh G, Sanna VK, Singh MK, Srivastava SK, Mahajan VA, Jadhav VH, Dutta K, Krishnan K, Chaudhary A, Agarwal SK, Mukherjee R, Burman AC. J Med Chem; 2007 Apr 19; 50(8):1744-53. PubMed ID: 17373779 [Abstract] [Full Text] [Related]
34. Synthesis and structure-activity relationships of constrained heterocyclic analogues of combretastatin A4. Arthuis M, Pontikis R, Chabot GG, Seguin J, Quentin L, Bourg S, Morin-Allory L, Florent JC. ChemMedChem; 2011 Sep 05; 6(9):1693-705. PubMed ID: 21732536 [Abstract] [Full Text] [Related]
35. Design, synthesis, and antitumor activity of new bis-aminomethylnaphthalenes. Bollini M, Casal JJ, Bruno AM. Bioorg Med Chem; 2008 Sep 01; 16(17):8003-10. PubMed ID: 18715786 [Abstract] [Full Text] [Related]
36. An investigation into the cytotoxicity and mode of action of some novel N-alkyl-substituted isatins. Vine KL, Locke JM, Ranson M, Pyne SG, Bremner JB. J Med Chem; 2007 Oct 18; 50(21):5109-17. PubMed ID: 17887662 [Abstract] [Full Text] [Related]